Mucin-Type O-GalNAc Glycosylation in Health and Disease
Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Standard
Mucin-Type O-GalNAc Glycosylation in Health and Disease. / Bagdonaite, Ieva; Pallesen, Emil M.H.; Nielsen, Mathias I.; Bennett, Eric P.; Wandall, Hans H.
The Role of Glycosylation in Health and Disease. Springer VS, 2021. s. 25-60 (Advances in Experimental Medicine and Biology; Nr. 1325).Publikation: Bidrag til bog/antologi/rapport › Bidrag til bog/antologi › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Mucin-Type O-GalNAc Glycosylation in Health and Disease
AU - Bagdonaite, Ieva
AU - Pallesen, Emil M.H.
AU - Nielsen, Mathias I.
AU - Bennett, Eric P.
AU - Wandall, Hans H.
N1 - Publisher Copyright: © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2021
Y1 - 2021
N2 - Mucin-type GalNAc O-glycosylation is one of the most abundant and unique post-translational modifications. The combination of proteome-wide mapping of GalNAc O-glycosylation sites and genetic studies with knockout animals and genome-wide analyses in humans have been instrumental in our understanding of GalNAc O-glycosylation. Combined, such studies have revealed well-defined functions of O-glycans at single sites in proteins, including the regulation of pro-protein processing and proteolytic cleavage, as well as modulation of receptor functions and ligand binding. In addition to isolated O-glycans, multiple clustered O-glycans have an important function in mammalian biology by providing structural support and stability of mucins essential for protecting our inner epithelial surfaces, especially in the airways and gastrointestinal tract. Here the many O-glycans also provide binding sites for both endogenous and pathogen-derived carbohydrate-binding proteins regulating critical developmental programs and helping maintain epithelial homeostasis with commensal organisms. Finally, O-glycan changes have been identified in several diseases, most notably in cancer and inflammation, where the disease-specific changes can be used for glycan-targeted therapies. This chapter will review the biosynthesis, the biology, and the translational perspectives of GalNAc O-glycans.
AB - Mucin-type GalNAc O-glycosylation is one of the most abundant and unique post-translational modifications. The combination of proteome-wide mapping of GalNAc O-glycosylation sites and genetic studies with knockout animals and genome-wide analyses in humans have been instrumental in our understanding of GalNAc O-glycosylation. Combined, such studies have revealed well-defined functions of O-glycans at single sites in proteins, including the regulation of pro-protein processing and proteolytic cleavage, as well as modulation of receptor functions and ligand binding. In addition to isolated O-glycans, multiple clustered O-glycans have an important function in mammalian biology by providing structural support and stability of mucins essential for protecting our inner epithelial surfaces, especially in the airways and gastrointestinal tract. Here the many O-glycans also provide binding sites for both endogenous and pathogen-derived carbohydrate-binding proteins regulating critical developmental programs and helping maintain epithelial homeostasis with commensal organisms. Finally, O-glycan changes have been identified in several diseases, most notably in cancer and inflammation, where the disease-specific changes can be used for glycan-targeted therapies. This chapter will review the biosynthesis, the biology, and the translational perspectives of GalNAc O-glycans.
KW - Cancer
KW - Carbohydrate-binding proteins
KW - GalNAc
KW - Glycans
KW - Mucins
KW - Proprotein processing
U2 - 10.1007/978-3-030-70115-4_2
DO - 10.1007/978-3-030-70115-4_2
M3 - Book chapter
C2 - 34495529
AN - SCOPUS:85115023395
SN - 978-3-030-70117-8
T3 - Advances in Experimental Medicine and Biology
SP - 25
EP - 60
BT - The Role of Glycosylation in Health and Disease
PB - Springer VS
ER -
ID: 280628793